Impact of non-alcoholic fatty liver disease on coronavirus disease 2019: A systematic review

doi:10.4254/wjh.v16.i8.1185

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (63)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-4)

Sum=55

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=2

Aug 27, 2024 (publication date) through Aug 22, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Hepatol. Aug 27, 2024; 16(8): 1185-1198
Published online Aug 27, 2024. doi: 10.4254/wjh.v16.i8.1185

Table 1 Baseline and study characteristics

Ref.	Publication year	Study design	Country	Patients		Age in years		Male		BMI in kg/m²		Hypertension		Diabetes mellitus
Ref.	Publication year	Study design	Country	NAFLD	Non-NAFLD	NAFLD	Non-NAFLD	NAFLD	Non-NAFLD	NAFLD	Non-NAFLD	NAFLD	Non-NAFLD	NAFLD	Non-NAFLD
Milic et al[29]	2022	Retrospective observational	Italy	130	105	60.5± 5.2	63 ± 6.4	95 (73.1)	67 (63.8)	30.8 ± 1.5	26.8 ± 1.5	43 (33.1)	27 (25.7)	26 (20.0)	7 (6.7)
Huang et al[30]	2020	Retrospective observational	China	86	194	43.3 ± 5.9	43.5 ± 7.4	50 (58.1)	96 (49.5)	27.3 ± 1.3	23.0 ± 1.1	18 (20.9)	27 (13.9)	10 (11.6)	11 (5.7)
Younossi et al[32]	2022	Retrospective observational	United States	553	2736	54.7 ± 15.8	54.0 ± 20.7	280 (50.6)	1340 (49.0)	32.6 ± 8.2	29.5 ± 6.8	346 (62.9)	1138 (41.6)	282 (51.0)	0 (0)
Vázquez-Medin et al[33]	2022	Retrospective observational	Mexico	79	60	54.6 ± 14.0	56.0 ± 17.5	62 (78.5)	42 (70.0)	N/d	N/d	3 (3.8)	9 (15.0)	0 (0)	8 (13.3)
Moctezuma-Velázquez et al[34]	2022	Retrospective observational	Mexico	359	111	51.3 ± 5.5	53.0 ± 6.9	231 (64.0)	67 (60.0)	31.2 ± 1.9	25.5 ± 1.1	122 (34.0)	25 (22.0)	111 (31.0)	15 (14.0)
Nath et al[35]	2022	Prospective observational	India	814	3169	47.1 ± 14.3	45.2 ± 16.1	673 (82.6)	2311 (72.9)	N/d	N/d	N/d	N/d	72 (43.3)	149 (43.5)
Vrsaljko et al[36]	2022	Retrospective observational	Croatia	120	96	58.0 ± 4.5	63.0 ± 4.6	78 (65.0)	59 (61.5)	31.5 ± 1.7	27.3 ± 1.9	47 (39.2)	45 (46.9)	20 (16.7)	10 (10.4)
Wang et al[37]	2021	Prospective observational	China	86	132	46.8 ± 16.5	48.8 ± 18.2	52 (60.5)	58 (43.9)	26.4 ± 5.3	21.2 ± 5.1	20 (23.3)	12 (9.1)	9 (10.5)	5 (3.8)
Madan et al[38]	2022	Retrospective observational	India	289	157	56.4 ± 14.3	58.3 ± 17.1	195 (67.5)	93 (59.2)	26.6 ± 5.2	N/d	N/d	N/d	129 (44.6)	68 (43.3)
Zoncapè et al[39]	2023	Retrospective observational	Italy	333	339	68.5 ± 14.0	73.7 ± 15.1	235 (70.6)	172 (55.3)	N/d	N/d	229 (68.8)	183 (54.0)	148 (44.4)	60 (17.7)
Brozat et al[31]	2024	Retrospective observational	United States	14667	14667	57.8 ± 15.1	57.3 ± 14.7	7356 (50.2)	7070 (48.2)	N/d	N/d	9761 (66.6)	9527 (65.0)	7051 (48.1)	7051 (48.1)

Data are n (%) or mean ± standard deviation. BMI: Body mass index; NAFLD: Non-alcoholic fatty liver disease; N/d: Not defined.

Citation: Moeed A, Larik MO, Fahim MAA, Rahman HAU, Najmi L, Changez MIK, Javed MM, Hasibuzzaman MA. Impact of non-alcoholic fatty liver disease on coronavirus disease 2019: A systematic review. World J Hepatol 2024; 16(8): 1185-1198
URL: https://www.wjgnet.com/1948-5182/full/v16/i8/1185.htm
DOI: https://dx.doi.org/10.4254/wjh.v16.i8.1185